Clinical Trial Update: DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis [Phase 2]

View source ↗

Summary

Phase 2 DUET study evaluating the safety, efficacy, pharmacokinetics and pharmacodynamics of orally administered TERN-501 as monotherapy and in combination with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• TERN-101 (TERN-101)
• TERN-501 (TERN-501)

Snippet

Sponsor: Terns, Inc. | Conditions: NASH - Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED | Results posted: 2025-03-12